Company Analysis

GT Biopharma, Inc. (GTBP)

Nasdaq: GTBP · Pharmaceutical Preparations · San Francisco, CA · filing with the SEC since 1995
Grade4.4
◀ Past 3.2● Present 3.1▶ Future 6.2
6 est.

Filings

350 filings since 2017 beside 53 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 13, 2026.

Filings a yearinsider forms included
3642504131305435
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest May 22, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Mar 2, 2026.Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Aug 29, 2025.SEC letters: 12 in the last 36 months, the newest May 11, 2026.
Insider forms 53

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Nov 11, 2026
Oct 20, 2026 EFFECT Registration effective
Oct 20, 2026 424B3 Shelf offering
Oct 13, 2026 DEF 14A Proxy statement
Oct 9, 2026 S-1 Listing registration
Oct 2, 2026 PRE 14A Preliminary proxy statement
Sep 29, 2026 D Private placement notice
Sep 25, 2026 8-K items 8.01, 9.01 Other event · Current report Sep 22, 2026
Sep 21, 2026 8-K items 1.01, 3.02, 3.03, 5.03, 9.01 Major agreement signed; Shares sold without registration; Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report Sep 18, 2026
Sep 15, 2026 8-K items 1.01, 3.02, 3.03, 5.03, 9.01 Major agreement signed; Shares sold without registration; Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report Sep 14, 2026
Sep 15, 2026 SCHEDULE 13G Large holder notice
Sep 3, 2026 8-K items 3.03, 5.03, 8.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Other event · Current report Sep 2, 2026
Aug 14, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Jul 2, 2026 DEF 14A Proxy statement
Jun 18, 2026 PRE 14A Preliminary proxy statement
Jun 12, 2026 8-K items 5.03, 9.01 Charter, bylaw or fiscal-year change · Current report Jun 8, 2026
May 22, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report May 20, 2026
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 13, 2026 EFFECT Registration effective
May 13, 2026 424B3 Shelf offering
May 11, 2026 CORRESP Reply to the SEC
May 6, 2026 UPLOAD SEC comment letter
Apr 30, 2026 S-1 Listing registration
Apr 7, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Apr 3, 2026
Mar 6, 2026 10-Q/A Quarterly report, amended Jun 30, 2025
Mar 6, 2026 10-Q/A Quarterly report, amended Sep 30, 2025
Mar 2, 2026 10-K Annual report Dec 31, 2025
Mar 2, 2026 8-K items 4.02, 9.01 Warning not to rely on past financial statements · Current report Mar 1, 2026
Jan 30, 2026 EFFECT Registration effective
Jan 30, 2026 424B3 Shelf offering
Jan 28, 2026 CORRESP Reply to the SEC
Jan 27, 2026 UPLOAD SEC comment letter
Jan 21, 2026 S-1 Listing registration
Jan 8, 2026 424B3 Shelf offering
Dec 2, 2025 EFFECT Registration effective
Dec 2, 2025 424B3 Shelf offering
Dec 2, 2025 CORRESP Reply to the SEC
Nov 26, 2025 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Nov 20, 2025
Nov 14, 2025 10-Q Quarterly report Sep 30, 2025
40 of 350 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton GTBP · research, not advice